DPP4 and diabetes mellitus: The DPP4 inhibition potential of oxytocin offers new molecular insights and perspectives of oxytocin and cyclic peptides in general as lead to serine protease inhibitors and can be used as future therapeutics to reduce blood glucose levels and to manage diabetes mellitus.